Spending Gaps In Global Health R&D Threaten Innovation Against Infectious Diseases, Study Shows

Health Policy Watch: New Analysis Reveals Significant Gaps In Funding For Health Innovation
“Many of the products critically needed to fight some of the world’s most prevalent infectious diseases are not likely to be developed. This is the outcome of a new analysis, which reveals significant gaps in funding for health innovation…” (Ueberschlag, 9/4).

New York Times: Vaccines Against HIV, Malaria and Tuberculosis Unlikely, Study Says
“…To make real progress against this variety of infectious diseases by 2030, the study concluded, the world must increase research spending to nearly $9 billion a year; it now spends only about $3 billion. But the world is moving in the opposite direction…” (McNeil, 9/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.